We hypothesize that these factors (FFAs, TNF-α, and resistin) and drug (rosiglitazone) may have a potential regulatory mechanism in obesity through the regulation of LYRM1 mRNA expression, thereby affecting insulin sensitivity. The gene discussed is TNF; the disease is Obesity.